Statement Of Cash Flows [Abstract]

Gentian Diagnostics ASA - Filing #2613853

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
24 794 NOK
24 794 NOK
17 469 NOK
17 469 NOK
Adjustments to reconcile profit (loss) [abstract]
Adjustments for decrease (increase) in inventories
8 904 NOK
2 652 NOK
Adjustments for decrease (increase) in trade accounts receivable
1 120 NOK
860,000 NOK
Adjustments for increase (decrease) in trade accounts payable
833,000 NOK
1 202 NOK
Adjustments for share-based payments
4 633 NOK
3 278 NOK
Cash flows from (used in) operating activities
27 053 NOK
12 509 NOK
4 848 NOK
7 661 NOK
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
1 024 NOK
2 734 NOK
Purchase of intangible assets, classified as investing activities
11 791 NOK
3 733 NOK
Cash flows from (used in) investing activities
12 815 NOK
274,000 NOK
4 848 NOK
4 574 NOK
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
570,000 NOK
462,000 NOK
Proceeds from borrowings, classified as financing activities
- NOK
497,000 NOK
Repayments of borrowings, classified as financing activities
3 691 NOK
2 469 NOK
Cash flows from (used in) financing activities
3 121 NOK
1 510 NOK
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
42 989 NOK
13 745 NOK
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
60,000 NOK
163,000 NOK
Cash and cash equivalents
114 936 NOK
157 985 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.